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Matrix	metalloproteinases	 (MMPs)	play	 impor-
tant	 roles	 in	 the	mechanism	of	 tumor	 invasion	and	
metastasis	by	selectively	degrading	the	extracellular	
matrix.	Among	the	various	MMPs,	gelatinases	(type-IV	
collagenases),	particularly	MMP-2	and	-9,	are	closely	
linked	with	tumor	malignancy	[11,	20],	and	the	increa-
sed	 levels	of	 these	enzymes	 in	 tumor	patients	are	
strongly	related	to	poor	prognosis	[7,	13,	14].
A	novel	endogenous	specific	MMP	inhibitor,	which	
was	designated	as	“reversion	 inducing	cysteine	 rich	
protein	with	Kazal	motifs”	(RECK),	has	been	recently	
isolated	[28].	RECK	inhibits	tumor	invasion	and	tumor	
angiogenesis	by	negatively	regulating	MMP-2,	-9,	and	
membrane-type	1-MMP	(MT1-MMP)	[19,	28].	 It	has	
been	suggested	 that	 this	membrane-anchored	gly-
coprotein	can	be	considered	as	one	of	the	reliable	pro-
gnostic	factors	in	several	tumor	patients	[10,	18,	24].	
In	the	majority	of	studies,	the	RECK	mRNA	expres-
sion	levels	were	quantified	by	Northern	blotting	[10,	18,	
28].	However,	the	RECK	mRNA	expression	levels	were	
reported	to	be	considerably	low	in	most	of	the	normal	
human	tissues	and	tumor	cells	[28].	Therefore,	to	detect	
the	low	expression	levels	of	the	RECK mRNA	by	Northern	
blotting,	a	large	volume	of	specimens	was	required	to	
purify	sufficient	amounts	of	the	mRNA.	In	view	of	this,	the	
quantitative	real-time	polymerase	chain	reaction	(PCR)	
analysis	is	advantageous	because	it	allows	detection	of	
the	mRNA	even	in	small	amounts	of	specimens,	and	it	
is	suitable	for	treating	a	large	number	of	samples.	Real	
time	PCR	had	been	used	to	quantify	human	and	canine	
RECK	mRNA	expression,	and	the	amplification	condition	
was	established	[24,	26,	27].	However,	this	technique	
has	not	been	established	for	murine	RECK.
The	purpose	of	the	present	study	was	to	investigate	
the	RECK	expression	levels	in	several	murine	tumor	cells	
by	employing	the	quantitative	PCR.	Subsequently,	in	order	
to	confirm	the	reliability	of	the	established	quantification	
technique	and	correlation	of	gelatinase	activity,	the	change	
in RECK	expression	and	gelatinase	secretion	was	studied	
in	tumor	cells	attached	to	the	extracellular	matrix.
Materials and Methods
Murine cell lines and cell culture.	The	following	
mouse	 tumor	cell	 lines	were	cultured	 in	Dulbecco’s	
Modified	 Eagle’s	 Medium	 (DMEM)	 containing	
1,000	U/ml	of	penicillin,	0.1	mg/ml	streptomycin,	and	
10%	fetal	bovine	serum	(FBS)	at	37	 °C	and	5%	CO2	
condition:	B16	(melanoma)	[12],	B16F1	(pulmonary	
metastatic	melanoma	derived	 from	B16)	 [23],	P815	
(mast	cell	tumor)	[8],	YAC-1	(lymphoma)	[15],	KLN205	
(squamous	cell	 carcinoma)	 [22],	S-180	 (sarcoma)	
[31],	Dunn	 (osteosarcoma)	 [21],	 LM8	 (pulmonary	
metastatic	melanoma	derived	from	Dunn)	[1].
RNA extraction and reverse transcription. Each	
tumor	cell	line	was	washed	twice	and	incubated	for	24	h	
in	a	culture	medium	lacking	FBS.	Then,	total	RNA	was	
extracted	by	the	guanidine	isothiocyanate	method	[5].	
The	total	RNA	(2	µg)	was	denatured	at	70	°C	for	10	min,	
immediately	cooled,	and	added	to	a	solution	containing	
200	units	of	M-MLV	reverse	transcriptase	(Invitrogen,	
USA),	50	nmol	dithiothreitol,	10	pmol	poly	(dT)	primer,	
and	20	nmol	dNTPs	in	a	total	volume	of	20	µl.	After	the	
poly	(dT)	primer	was	annealed	at	20	°C	for	10	min,	cDNA	
synthesis	was	performed	at	37	°C	for	1	h.
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Quantitative pcR analysis of RecK gene ex-
pression in mouse tumor cell lines. All	PCR	reac-
tions	were	performed	using	a	detection	kit	(Lightcy-
cler-FirstStart	DNA	Master	SYBR	Green	kit,	Roche	
Molecular	Biochemicals,	Mannheim,	Germany).	The	
primer	pairs	used	 for	amplifying	RECK	mRNA	were	
as	 follows:	sense,	5ʹ-GCA	TGC	AAG	CAG	GCA	TCT	
TC-3ʹ	and	antisense,	5ʹ-CTG	TGG	ACT	GAT	AGA	GGC	
AC-3ʹ.	To	ensure	correctness	of	mRNA	extraction	and	
reverse-transcription	and	standardize	 the	samples,	
all	 the	 samples	were	 subjected	 to	PCR	amplifica-
tion	using	oligonucleotide	primers	 specific	 for	 the	
constitutively	 expressed	gene	glyceraldehydes-3-
phoshate-dehydrogenase	(GAPDH).	The	primer	pairs	
for	amplifying	GAPDH	mRNA	were	as	follows:	sense,	
5ʹ-GAA	GGT	CGG	TGT	GAA	CGG	ATT-3ʹ	and	antisense,	
5ʹ-GAA	GAC	ACC	AGT	AGA	CTC	CAC	GAC	ATA-3ʹ.	
The	PCR	reaction	mixture	containing	the	following	
reaction	components	was	prepared	to	the	indicated	
end	concentration:	13.4	µl	water,	2.4	µl	MgCl2	(4	mM),	
0.1	µl	forward	primer	(100	µM),	0.1	µl	reverse	primer	
(100	µM),	and	2.0	µl	LightCycler	Fast	Start	DNA	Master	
SYBR	Green	I	(Roche	Molecular	Biochemicals).	As	a	
PCR	template,	18	µl	of	master-mix	and	2	µl	of	cDNA	as	
a	PCR	template	were	added	to	glass	capillaries.	
The	cycling	conditions	were	as	follows:	initial	dena-
turation	at	95	°C	for	30	s,	followed	by	35	cycles	(RECK)	
or	30	cycles	(GAPDH)	at	95	°C	for	touchdown	(0	s),	60	°C	
for	5	s,	and	72	°C	for	10	s.	In	order	to	improve	the	SYBR	
Green	I	quantification,	the	temperature	of	the	fluores-
cence	measurement	point	was	set	at	84	°C	(RECK)	and	
83	°C	(GAPDH).	The	expression	level	of	each	mRNA	in	
the	tissue	samples	was	determined	relative	to	the	stan-
dard	curve	by	using	the	LightCycler	computer	software	
(Roche	Molecular	Biochemicals).	The	identity	of	each	
PCR	product	was	confirmed	by	electrophoresis.
stimulation by extracellular matrix.	Matrigel-
coated	plates	were	used	to	stimulate	Dunn	and	LM8	
cells	by	direct	contact	with	 the	extracellular	matrix.	
Matrigel	(BD	Biosciences,	USA)	is	composed	of	the	
extracellular	matrix	 that	 is	 secreted	by	Engelbreth-
Holm-Swarm	mouse	 sarcoma	cells.	Matrigel	was	
diluted	to	0.1	mg/ml	with	phosphate-buffered	saline	
(PBS)	on	ice.	Subsequently,	1	ml	of	the	solution	was	
poured	into	each	well	of	the	6-well	cell	culture	plates.	
These	solutions	were	dried	by	leaving	plates	overnight	
on	a	clean	bench	under	an	air	flow.	Cell	culture	medium	
containing	10%	FBS	 (2	ml)	was	poured	2	h	before	
seeding	 it	with	 the	cell	 suspension	solution	 (2	ml).	
The	concentration	of	cells	in	the	culture	medium	was	
adjusted	to	1.0	x	106	cells/ml.	After	24	h	of	incubation,	
cells	were	washed	 twice	with	 serum	 free	medium.	
The	collection	of	RNA	from	each	cell	line	and	culture	
medium	was	performed	after	24	h.
gelatin zymography. Gelatin	 zymography	was	
employed	to	investigate	the	correlation	between	murine	
RECK	mRNA	expression	and	gelatinize	activity.	By	using	
the	previously	 reported	method,	gelatin	zymography	
was	performed	[2,	29].	Briefly,	20	µl	of	the	supernatant	
of	each	conditioned	medium	was	mixed	with	an	equal	
volume	of	2	x	SDS-PAGE	sample	buffer	without	boiling.	
The	samples	were	fractionated	by	electrophoresis	on	a	
10%	polyacrylamide	gel	containing	gelatin	(0.5	mg/mL).	
In	order	to	remove	the	SDS,	the	gels	were	soaked	in	
2.5%	Triton	X-100	containing	10	mM	Tris	(pH	8.0)	for	
30	min	at	room	temperature	and	incubated	in	a	diges-
tion	buffer	(50	mM	Tris	[pH	8.0],	0.5	mM	CaCl2,	and	
1	µM	ZnCl2)	at	37	°C	for	30	h	to	enable	the	proteinase	
digestion	of	the	substrate.	The	gels	were	stained	with	
0.25%	Coomassie	brilliant	blue	R-250	and	destained	
with	10%	isopropanol	and	5%	acetic	acid.	The	gelati-
nolytic	activities	were	observed	due	to	the	appearance	
of	clear	bands	of	digested	gelatin	against	a	dark	blue	
background	of	stained	gelatin.
statistical analysis.	For	the	comparison	of	the	mu-
rine	RECK	expression	levels	in	tumor	cells,	analysis	of	va-
riance	followed	by	Scheffe’s	multiple	comparison	as	the	
post-hoc	test	was	performed.	For	the	comparison	of	con-
trol	and	stimulated	cells,	the	Student’s	t-test	was	used.	
Differences	were	considered	significant	when	p	<	0.05.	
The	statistical	analyses	were	performed	using	the	Stat	
View	5.0	software	(SAS	Institute,	Cary,	NC,	USA).
results and discussion
RecK gene expression in murine tumor cells. 
Quantitative	real	time	PCR	could	accurately	measure	the	
amount	of	RECK	mRNA,	and	the	amplified	cDNA	comp-
letely	corresponded	with	a	part	of	the	reported	murine	
RECK gene	(Fig.	1).	Northern	blotting	was	used	in	most	
of	the	previous	studies	to	quantify	the	expression	level	
of	the	RECK	mRNA	[10,	18,	28].	The	findings	of	these	
studies	were	that	the	RECK	mRNA	expression	level	 in	
normal	human	tissues	and	tumor	cells	was	considerably	
low.	Therefore,	to	detect	the	low	RECK	mRNA	expression	
by	Northern	blotting,	it	was	necessary	to	purify	the	poly	
A	(+)	mRNA	from	the	total	RNA	and	obtain	an	adequate	
number	of	samples.	The	quantitative	PCR	used	in	this	
study	indicated	that	this	was	an	easy,	useful,	and	sensitive	
technique	to	quantify	the	mRNA	levels	of	specific	genes.	
Moreover,	the	process	did	not	involve	a	treatment	step	
for	purifying	the	mRNA	from	total	RNA.
fig. 1. Standard	curve	 for	quantification	of	murine	 reversion	
inducing	cysteine	rich	protein	with	Kazal	motifs	(RECK)	mRNA.	
All	measurements	of	murine	RECK was	performed	when	the	error	
value	was	less	than	0.2
The	murine	tumor	cells	showed	variable	levels	of	mu-
rine	RECK gene	expression	(Fig.	2).	Although	most	cell	
lines	showed	extremely	low	RECK	mRNA	expression,	two	
osteosarcoma	cell	lines	showed	a	clear	expression	and	
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the	S-180	cell	—	line	comparatively	higher	RECK	mRNA	
expression.	The	previous	studies	reported	that	there	was	
little	RECK	mRNA	expression	in	the	murine	and	human	
tumor	cells	[28].	However,	in	canine	osteosarcoma	cell	
line,	 the	high	RECK	mRNA	expression	was	confirmed	
[26].	 In	 the	present	study,	murine	osteosarcoma	was	
found	to	exhibit	significantly	higher	levels	of	RECK	mRNA	
compared	to	other	tumor	cell	lines.	The	highly	metastatic	
LM8	cells	derived	from	the	Dunn	osteosarcoma	cell	line	
showed	significantly	lower	expression	than	parental	cell	
line.	As	it	was	reported	[28],	the	more	malignant	tumor	
cells	exhibited	lower	RECK	mRNA	expression	compared	
to	parental	cell	lines.	In	particular,	B16F1	and	LM8	cells,	
more	metastatic	than	the	cell	lines	that	they	are	derived	
from	(B16	and	Dunn,	respectively)	[1,	23],	are	showed	
to	possess	lower	RECK	mRNA	expression.	
fig. 2. Murine	RECK	gene	expression	in	various	types	of	tumor	
cells.	GAPDH:	glyceraldehyde-3-phoshate-dehydrogenase
Regulation of RecK mRNA expression under 
extracellular matrix stimulation. Osteosarcoma	
cells	that	were	cultured	on	matrigel-coated	plates	were	
attached	to	the	bottom	of	the	plates	in	a	manner	similar	
to	that	observed	on	standard	culture	plates.	However,	
the	cells	exhibited	different	morphology	depending	on	
the	extracellular	matrix	present	in	the	culture	plates.	
The	 tumor	cells	cultured	on	matrigel-coated	plates	
were	fibroblastic,	although	the	cells	appeared	to	be	
osteoblastic	when	cultured	on	standard	plates.	The	
RECK	mRNA	expression	in	the	cells	grown	on	matri-
gel	was	significantly	lower	(by	2/3	nad	½	in	Dunn	and	
LM8	cells	respectively)	than	that	in	the	cells	grown	in	
standard	conditions	(Fig.	3).	
fig. 3. The	RECK gene	expression	in	the	osteosarcoma	cell	lines	
upon	contact	with	matrigel.	The	RECK	expression	in	Dunn	cells	
grown	in	the	matrigel-coated	flask	was	significantly	lower	than	
that	in	control	flasks	(*p <	0.05).	LM8	cells	also	showed	changes	
identical	to	that	shown	by	Dunn
There	was	one	report	stating	that	type-1	downregula-
tion	of	the	RECK	expression	in	human	glioma	cells	grown	
on	collagen-gel	coated	plate	[6].	However,	our	data	(un-
published)	indicated	that	type-1	collagen	did	not	cause	
RECK downregulation	in	the	murine	osteosarcoma.	In	
the	present	report,	RECK	expression	in	Dunn	and	LM8	
cells	was	downregulated	due	to	direct	contact	with	matri-
gel	—	an	extracellular	matrix	secreted	by	the	Engelbreth-
Holm-Swarm	mouse	sarcoma	[16].	The	requirement	for	
direct	contact	of	the	cells	with	an	extracellular	matrix	to	
induce RECK downregulation	might	be	due	to	the	fact	
that	RECK	is	a	membrane-anchored	protein.	
gelatin zymography. In	the	present	study,	gelatin	
zymography	was	performed	to	validate	the	correlation	
between	RECK	downregulation	and	gelatinase	activities	
and	secretion.	The	MMPs	are	secreted	 from	several	
types	of	cells	as	inactivated	proenzymes	that	are	sub-
sequently	activated	by	other	MMPs	or	serine	proteina-
ses	[9].	Gelatin	zymography	is	a	method	that	enables	
visualizing	the	amount	of	gelatinases	as	clear	bands.	
This	technique	is	distinct	from	Western	blotting	and	en-
zyme-linked	immunosorbent	assay	(ELISA)	[3]	because	
it	can	measure	not	only	activated	gelatinases	but	also	
simultaneously	measure	inactivated	pro-MMPs	[4,	30].	
RECK	is	a	membrane-anchored	protein	that	negatively	
regulates	secretion	and	activities	of	gelatinases.	Thus,	
the	data	obtained	by	measuring	gelatinase	activity	can	
be	used	for	evaluation	of	RECK	expression.
Initially,	zymographic	analysis	was	carried	out	on	the	
same	medium	on	which	the	Dunn	osteosarcoma	cells	
were	cultured	without	any	stimulation.	No	visible	band	
indicating	the	secretion	of	pro-MMP-2	and	pro-MMP-9	
was	observed	(Fig.	4).	LM8	cells	secreted	larger	amounts	
of	pro-MMP-2	 in	 their	conditioned	medium,	and	this	
result	was	consistent	 to	 that	of	a	previous	report	 [1].	
When	these	tumor	cells	are	in	contact	with	matrigel,	they	
exhibited	increased	gelatinases	secretion.	The	contact	
of	the	cells	with	matrigel	induced	secretion	of	MMP-9	in	
Dunn	cells	and	secretion	of	both	the	gelatinases	MMP-2	
and	9	in	LM8	cells.	These	results	might	indicate	a	close	
correlation	between	the	increased	gelatinase	secretion	
and	downregulation	of	murine	RECK	mRNA.
fig. 4. Gelatinases	activity	observed	 in	 the	 two	 types	of	os-
teosarcoma	cells	stimulated	by	matrigel.	Gelatinase	activation	
was	induced	due	to	direct	contact	with	matrigel.	MMP:	Matrix	
metalloproteinase
It	 is	known	 that	 the	 level	of	gelatinase	activity	 is	
altered	in	tumor	tissues	[1,	10,	18,	25].	Several	reports	
have	shown	 that	gelatinases	can	be	upregulated	or	
activated	in	osteosarcoma	cells	[17,	20].	In	the	present	
study,	we	have	shown	that	direct	contact	with	matrigel	
induced	MMP	secretion	and	RECK	downregulation.
Experimental	Oncology	29, 30–34, 2007 (March) 33	 	 	 	
references
1. Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S, 
Yoshikawa H. Establishment and characterization of a murine 
osteosarcoma cell line (LM8) with high metastatic potential 
to the lung. Int J Cancer 1998; 76: 418–22.
2. Becerril C, Pardo A, Montano M, Ramos C, Ramirez R, 
Selman M. Acidic fibroblast growth factor induces an antifi­
brogenic phenotype in human lung fibroblasts. Am J Respir 
Cell Mol Biol 1999; 20: 1020–7.
3. Chen F, Eriksson P, Hansson GK, Herzfeld I, Klein M, 
Hansson LO, Valen G. Expression of matrix metalloproteina­
se 9 and its regulators in the unstable coronary atherosclerotic 
plaque. Int J Mol Med 2005; 15: 57–65. 
4. Chen Y, Hozawa S, Sawamura S, Sato S, Fukuyama N, 
Tsuji C, Mine T, Okada Y, Tanino R, Ogushi Y. Nakazawa H. 
Deficiency of inducible nitric oxide synthase exacerbates he­
patic fibrosis in mice fed high­fat diet. Biochem Biophys Res 
Commun 2004; 326: 45–51.
5. Chomczynski P, Sacchi N. Single­step method of RNA 
isolation by acid guanidinium thiocyanate­phenol­chloroform 
extraction. Anal Biochem 1987; 162: 156–9. 
6. Correa TC, Brohem CA, Winnischofer SM, da Silva 
Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-
Engler SS. Downregulation of the RECK­tumor and metastasis 
suppressor gene in glioma invasiveness. J Cell Biochem 2006; 
99: 156–67.
7. Dalberg K, Eriksson E, Enberg U. Gelatinase A, membrane 
type 1 matrix metalloproteinase, and extracellular matrix metal­
loproteinase inducer mRNA expression: correlation with invasive 
growth of breast cancer. World J Surg 2000; 24: 334–40. 
8. Demehri S, Corbin A, Loriaux M, Druker BJ, Deininger MW. 
Establishment of a murine model of aggressive systemic mastocy­
tosis/mast cell leukemia. Exp Hematol 2006; 34: 284–8.
9. Foda HD, Zucker S. Matrix metalloproteinases in cancer 
invasion, metastasis and angiogenesis. Drug Discov Today 
2001; 9: 478–82.
10. Furumoto K, Arii S, Mori A, Furuyama H, Gorrin 
Rivas MJ, Nakao T, Isobe N, Murata T, Takahashi C, Noda M, 
Imamura M. RECK gene expression in hepatocellular carcino­
ma: correlation with invasion­related clinicopathological factors 
and its clinical significance. Reverse­inducing­cysteine­rich 
protein with Kazal motifs. Hepatology 2001; 33: 189–95.
11. John A, Tuszynski G. The role of matrix metallopro­
teinases in tumor angiogenesis and tumor metastasis. Pathol 
Oncol Res 2001; 7: 14–23.
12. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, 
Opolon P, Lassau N, Bourhis J, Deutsch E. Angiogenesis and tumor 
growth inhibition by a matrix metalloproteinase inhibitor targeting 
radiation­induced invasion. Mol Cancer Ther 2005; 4: 1717–28.
13. Kawamata H, Uchida D, Hamano H. Active­MMP2 in 
cancer cell nests of oral cancer patients: correlation with lymph 
node metastasis. Int J Oncol 1998; 13: 699–704. 
14. Kawano N, Osawa H, Takaaki I. Expression of gelatina­
se A, tissue inhibitor of metalloproteinases­2, matrilysin, and 
trypsin(ogen) in lung neoplasms. Hum Pathol 1997; 28: 613–22.
15. Kim GY, Lee JY, Lee JO, Ryu CH, Choi BT, Jeong YK, 
Lee KW, Jeong SC, Choi YH. Partial characterization and 
immunostimulatory effect of a novel polysaccharide­protein 
complex extracted from Phellinus linteus. Biosci Biotechnol 
Biochem 2006; 70: 1218–26.
16. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, 
Tryggvason K, Martin GR. Isolation and characterization of 
type IV procollagen, laminin, and heparan sulfate proteoglycan 
from the EHS sarcoma. Biochemistry 1982; 21: 6188–93.
17. Kurogi T, Nabeshima K, Kataoka H, Okada Y, Koono M. 
Stimulation of gelatinase B and tissue inhibitors of metallopro­
teinase (TIMP) production in co­culture of human osteosar­
coma cells and human fibroblasts: gelatinase B production was 
stimulated via up­regulation of fibroblast growth factor (FGF) 
receptor. Int J Cancer 1996; 66: 82–90.
18. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Na-
kajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, 
Mori T, Wada M, Noda M, Imamura M. RECK expression in 
pancreatic cancer: its correlation with lower invasiveness and 
better prognosis. Clin Can Res 2003; 9: 1779–84.
19. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sa-
sahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, 
Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, 
Seiki M, Itohara S, Takahashi C, Noda M. The membrane­an­
chored MMP inhibitor RECK is a key regulator of extracellular 
matrix integrity and angiogenesis. Cell 2001; 107: 789–800.
20. Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, 
Sato H, Seiki M, Yamashita K, Hayakawa T. Induction and stimu­
lation of 92­kDa gelatinase/type IV collagenase production in 
osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor 
alpha. Biochem Biophys Res Commun 1990; 171: 610–7.
21. Okamoto T, Yamada N, Tsujimura T, Sugihara A, 
Nishizawa Y, Ueda H, Kashiwamura S, Tsutsui H, Futani H, 
Maruo S, Okamura H, Terada N. Inhibition by interleukin­18 
of the growth of Dunn osteosarcoma cells. J Interferon Cyto­
kine Res 2004; 24: 161–7.
22. O-Sullivan I, Ng LK, Martinez DM, Kim TS, Chopra A, 
Cohen EP. Immunity to squamous carcinoma in mice immunized 
with dendritic cells transfected with genomic DNA from squa­
mous carcinoma cells. Cancer Gene Ther 2005; 12: 825–34.
23. Sloane BF, Honn KV, Sadler JG, Turner WA, Kimp-
son JJ, Taylor JD. Cathepsin B activity in B16 melanoma 
cells: a possible marker for metastatic potential. Cancer Res 
1982; 42: 980–6.
24. Span PN, Sweep CG, Manders P, Beex LV, Leppert D, 
Lindberg RL. Matrix metalloproteinase inhibitor reversion­
inducing cysteine­rich protein with Kazal motifs: a prognostic 
marker for good clinical outcome in human breast carcinoma. 
Cancer 2003; 97: 2710–5.
25. Stetler-Stevenson WG. The role of matrix metallopro­
teinases in tumor invasion, metastasis, and angiogenesis. Surg 
Oncol Clin N Am 2001; 10: 383–92.
26. Takagi S, Kato Y, Asano K, Ohsaki T, Bosnakovski D, 
Hoshino Y, Okumura M, Kadosawa T, Fujinaga T. Matrix me­
talloproteinase inhibitor RECK expression in canine tumors. 
J Vet Med Sci 2005; 67: 761–7.
27. Takagi S, Kitamura T, Hosaka Y, Ohsaki T, Bosnakovs-
ki D, Kadosawa T, Okumura M, Fujinaga T. Molecular cloning 
of canine membrane­anchored inhibitor of matrix metallopro­
teinase, RECK. J Vet Med Sci 2005; 67: 385–91.
28. Takahashi C, Sheng Z, Horan TP, Kitayama H, 
Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimo-
to A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M. Regulation of 
matrix metalloproteinase­9 and inhibition of tumor invasion 
by the membrane­anchored glycoprotein RECK. Proc Natl 
Acad Sci USA 1998; 95: 13221–6.
29. Tsuruda T, Boerrigter G, Huntley BK, Noser JA., Cataliot-
ti A, Costello-Boerrigter LC, Chen HH, Burnett Jr JC. Brain 
natriuretic peptide is produced in cardiac fibroblasts and induces 
matrix metalloproteinases. Circ Res 2002; 91: 1127–34.
30. Winnica DE, Novella ML, Dematteis A, Coronel CE. Tryp­
sin/acrosin inhibitor activity of rat and guinea pig caltrin proteins. 
Structural and functional studies. Biol Reprod 2000; 63: 42–8. 
31. Yuan H, Song J, Li X, Li N, Dai J. Immunomodulation 
and antitumor activity of kappa­carrageenan oligosaccharides. 
Cancer Lett 2006; 243: 228–34.
34	 Experimental	Oncology	29,	30–34,	2007	(March)
экспрессия ингибитора мембраносвязанных 
матриксных металлопротеиназ rec�� в линиях   
опухолевых клеток мыши
Показано, что эндогенный ингибитор матриксных протеиназ (MMП) RECK может служить надежным прогностическим 
маркером для некоторых типов опухолей, однако его экспрессия в большинстве нормальных и неопластических тканей 
крайне низкая, поэтому возникают сложности, связанные с детекцией таковой. Цель работы — разработка количествен-
ного метода определения экспрессии мРНК для использования в экспериментальных исследованиях. Для дальнейшего 
подтверждения надежности разработанного метода исследованы изменения экспрессии RECK и секреции желатиназ в 
опухолевых клетках при стимуляции внеклеточным матриксом. Методы: в работе использовали несколько линий опу-
холевых клеток мыши, в которых экспрессию мРНК RECK анализировали методом ПЦР в режиме реального времени, 
активность желатиназ — методом зимографии. Результаты: экспрессию мРНК RECK количественно оценили методом 
ПЦР в режиме реального времени, причем среди исследованных клеточных линий наиболее высокий уровень экспрессии 
RECK выявили в клетках остеосаркомы. Экспрессия RECK в клетках остеосаркомы подавлялась при контакте с культу-
ральным пластиком, обработанным матригелем, вследствие повышения секреции желатиназ. Выводы: для количественной 
оценки экспрессии мРНК RECK может быть использован метод ПЦР в режиме реального времени. 
Ключевые слова: RECK, желатиназа, ингибитор MMП, метод ПЦР в режиме реального времени, остеосаркома.          
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